These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 14983973

  • 1. Oxygen free radical traps for the treatment of ischemia-associated organ injury.
    Jackson DM, Sammut IA.
    Curr Opin Investig Drugs; 2004 Jan; 5(1):50-4. PubMed ID: 14983973
    [Abstract] [Full Text] [Related]

  • 2. Nitrone spin on cerebral ischemia.
    Doggrell SA.
    Curr Opin Investig Drugs; 2006 Jan; 7(1):20-4. PubMed ID: 16425667
    [Abstract] [Full Text] [Related]

  • 3. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR, Ashwood T.
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
    [Abstract] [Full Text] [Related]

  • 4. NXY-059: review of neuroprotective potential for acute stroke.
    Fong JJ, Rhoney DH.
    Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
    [Abstract] [Full Text] [Related]

  • 5. NXY-059, a nitrone with free radical trapping properties inhibits release of cytochrome c after focal cerebral ischemia.
    Han M, He QP, Yong G, Siesjö BK, Li PA.
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1249-52. PubMed ID: 14983994
    [Abstract] [Full Text] [Related]

  • 6. Brain attack. Acute therapeutic interventions. Free radical scavengers and antioxidants.
    Hall ED.
    Neurosurg Clin N Am; 1997 Apr; 8(2):195-206. PubMed ID: 9113701
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.
    Green AR, Lanbeck-Vallén K, Ashwood T, Lundquist S, Lindström Böö E, Jonasson H, Campbell M.
    Brain Res; 2006 Feb 09; 1072(1):224-6. PubMed ID: 16448628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P, Schulz R, Baxter GF.
    Pharmacol Rev; 2007 Dec 09; 59(4):418-58. PubMed ID: 18048761
    [Abstract] [Full Text] [Related]

  • 11. Evolving therapeutic approaches to treating acute ischemic stroke.
    Weinberger JM.
    J Neurol Sci; 2006 Nov 15; 249(2):101-9. PubMed ID: 17005205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke.
    Koziol JA, Feng AC.
    Stroke; 2006 Oct 15; 37(10):2644-7. PubMed ID: 16946150
    [Abstract] [Full Text] [Related]

  • 15. Vitamin E can protect myocardium against oxidative damage.
    Guarnieri C, Giordano E, Muscari C, Caldarera CM.
    Cardiovasc Res; 1995 Jul 15; 30(1):153-5; discussion 156-7. PubMed ID: 7553718
    [No Abstract] [Full Text] [Related]

  • 16. Intervention strategies for neonatal hypoxic-ischemic cerebral injury.
    Perlman JM.
    Clin Ther; 2006 Sep 15; 28(9):1353-65. PubMed ID: 17062309
    [Abstract] [Full Text] [Related]

  • 17. NXY-059. Centaur.
    Lapchak PA.
    Curr Opin Investig Drugs; 2002 Dec 15; 3(12):1758-62. PubMed ID: 12528313
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.